Mydecine Reports Financial Results for the Second Quarter of Fiscal Year 2022

16.08.2022 - DENVER, Aug. 15, 2022 (GLOBE NEWSWIRE) - Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) ('Mydecine' or the 'Company'), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today ...

Related Keywords

Colorado ,United States ,Canada ,Netherlands ,Denver ,Canadian ,Damon Michaels ,Joshua Bartch ,Instagram ,Mydecine Innovations Group Inc ,Youtube ,Mydecine Innovations Group ,Linkedin ,Twitter ,Net Loss ,Innovations Group ,Chief Operating Officer ,Chief Executive Officer ,